|
000
| 02282cam 2200385zi 4500 |
|---|
| 001 | 9.874552 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107164225 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 190820e201906##onc o f000 0 eng d |
|---|
| 020 | |a9780660312880 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-273/2019E-1-PDF |
|---|
| 245 | 00|aGuidance document : |bregulatory requirements for drug identification numbers (DINs). |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada,|cJune 2019. |
|---|
| 264 | 4|c©2019 |
|---|
| 300 | |a1 online resource (28 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aTitle from cover. |
|---|
| 500 | |aIssued also in French under title: Ligne directrice : exigences réglementaires associées à une identification numérique attribuée à une drogue (DIN). |
|---|
| 500 | |a"Date adopted: 2019/05/03; effective date: 2019/05/03; administrative changes date: 2019/06/19." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 520 | |a"When Health Canada authorizes a drug to be marketed in Canada, a Drug Identification Number (DIN) is issued to the manufacturer and printed on the package labels. A DIN indicates that the evaluation of the drug determined that it met the relevant requirements of the Food and Drugs Act and its regulations and the drug has a favourable risk/benefit profile. Manufacturers of prescription and non‐prescription drugs must obtain a DIN before they are marketed in Canada. Market authorization of a drug may require the additional issuance of a Notice of Compliance (NOC)"--Introduction, page 8. |
|---|
| 692 | 07|2gccst|aDrug labelling |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 775 | 08|tLigne directrice : |w(CaOODSP)9.874556 |
|---|
| 794 | |tGuidance document : |w(CaOODSP)9.899686 |
|---|
| 795 | |tGuidance document : |w(CaOODSP)9.870481 |
|---|
| 856 | 40|qPDF|s307 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H164-273-2019-1-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/regulatory-requirements-drug-identification-numbers/document.html |
|---|